Opioid Crisis Accountability Act of 2018

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing H.R. 6491 Reporting of Information on Distribution of Opioids H.R. 6608 Prescription Drug Monitoring Programs Data Collection H.R. 5812 Controlled Substance Overdose Prevention Activities

Client expense: $1,070,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas **Issues lobbied without specific bill number: Workers' Compensation Medicare Set-Aside H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing

Client expense: $1,590,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

S. 1112/HR 1318 - Maternal Accountability Act/Preventing Maternal Deaths: Promoted preventing maternal mortality. S. 2691 - Opioid Crisis Accountability Act - Responding to Senate inquiry on restricting the marketing and distribution of opioids. S. 2704 - Medicare Beneficiary Opioid Addiction Treatment: Responding to senate inquiry in support of Opioid treatment. S 2852, S. 2852 & House Draft: ASPR & Pandemic & All Hazards Preparedness Act reauthorization: Public Health preparedness. S. 3014 - Rural Physician Workforce Production Act: Graduate Medical Education reform, rural physician workforce; seek co-sponsors on rural GME bill; seek House sponsors; Seek Co-sponsors on legislation to amend the title XVIII of the Social Security Act to support rural residency training funding. S 3158 - HRSA funding-FY 2019 HHS Appropriations: Funding for access to primary care, health professional training grants, Title X family planning. S. 3158 - CDC funding-FY 2019 HHS Appropriations: Chronic Disease Prevention & Health Promotion, Immunization. S. 3158 - Increased overall spending FY19 HHS Appropriations: AAFP FY 2019 federal spending priorities for primary care training, research & access. S. 3158 - Rural Health programs funding-FY 2019 HHS Appropriations: Eliminate disparities of access to quality care for all populations. S. 3158 - Gun Violence Prevention CDC funding-FY 2019 HHS Appropriation:Gun violence is a public health emergency. S 3158 - AHRQ funding-FY 2019 HHS Appropriations:Primary Care Research, US Preventive Services Task Force. S. 3158 - SAMHSA funding-FY 2019 HHS Appropriations: Provide adequate resources for substance abuse treatment. S. 3158 - CMS funding-FY 2019 HHS Appropriations S 3158 & House draft: Support effective, efficient management of Medicare, Medicaid, CHIP & Marketplaces. HR 2 - Agriculture Improvement Act: Issued concerns about the SNAP cuts and health care policies. HR 5858 - Primary Care Patient Protection Act: Seek co-sponsors for legislation to require coverage without a deductible of certain primary care services by high deductible health plans. H.R. 6310; H.R. 6317 - Direct Primary Care: Advocate for co-sponsorship of bill to allow Americans with HSAs to use their accounts to pay for DPC arrangements. No Bill No. - Opioid Epidemic: Support evidence based approaches to curb opioid abuse; Commented on E&C Bills. Advocated for the ACE Research Act and CONNECTIONS Act. No Bill No. - Overcoming Gaps in the Treatment of Mental Illness Research: Improved mental health services. No Bill No. - Shoulder Injury Related to Vaccine Administration: Responding to Senate inquiry on vaccine injury prevention. No Bill No. - Paid sick leave to benefit American workers: Public Health. No Bill No. - Oppose tobacco riders in Ag bill & cut to CDCs Office on Smoking and Health: Public Health/Tobacco Control. No Bill No. - National Health Services Corps.: Sustainable funding for NHSC to provide access and debt relief. No Bill No. - Administrative Burden: Administrative simplification to stem physician burnout; Advocate for end to E/M documentation guidelines, AUC, etc. in WM Red Tape Initiative. No Bill No. - Advanced Primary Care Alternative Payment Model: New Medicare alternative payment model; Seek co-signors on letter to HHS on APC-APM payment model. No Bill No. - HHS on the HPV draft paper: How to improve HPV vaccination rates. No Bill No.- Congressional Primary Care Caucus: Urge members to join the Primary Care Caucus to achieve the triple aim in healthcare. No Bill No. - Direct Primary Care:advocate for co-sponsorship of bill to allow Americans with HSAs to use DPCs. No Bill No. - Insurance Market Stabilization: Outreach on ACA policies and possible market stabilization. No Bill No. - Drug Pricing: Provided feedback ont he CREATES Act and PACED Act. Drafted a drug pricing letter.

Client expense: $795,726 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE